BD140 [for Albumin binding assay] | CAS 1201643-08-4

BD140 [for Albumin binding assay] is a fluorescence-based research reagent designed to quantify albumin-ligand interactions in chemical biology and drug discovery workflows. In typical binding studies, BD140 provides a measurable fluorescence readout that changes upon association with albumin, enabling comparative evaluation of candidate binders and binding conditions. Researchers use it to support screening, mechanistic binding characterization, and assay development where albumin is used as a physiologically relevant binding protein model.

1. Albumin Binding Assay

BD140 [for Albumin binding assay] is used in fluorescence binding studies to evaluate how small molecules, probes, or candidate ligands associate with albumin. In practice, researchers set up controlled titrations of albumin with the test compound and monitor the fluorescence response to generate binding curves for relative affinity comparisons and condition-dependent effects. This format is frequently adopted in early-stage medicinal chemistry and chemical biology to prioritize ligands with favorable albumin interaction profiles and to support interpretation of protein-binding behavior in vitro.

2. Fluorescence Quenching Studies

BD140 [for Albumin binding assay] is commonly incorporated into fluorescence quenching or fluorescence recovery workflows where albumin binding modulates the observed emission signal. Chemical biology teams use the reagent to examine how different ligand classes influence the fluorescence output in the presence of albumin, supporting rank-ordering of binding competitors and assessment of binding-related trends across experimental series. The fluorescence readout is compatible with standard plate-reader and cuvette-based measurements used in binding characterization and screening-support studies.

3. Ligand Screening Optimization

BD140 [for Albumin binding assay] supports assay development and optimization for protein-binding screens by providing a consistent fluorescence-based response tied to albumin association. Researchers use it to refine experimental parameters such as reagent ratios, incubation timing, and buffer conditions to achieve reproducible fluorescence behavior suitable for comparative testing of multiple compounds. This makes BD140 a practical tool in workflow development for libraries of candidate ligands, where albumin binding is used as a key in vitro property to guide downstream prioritization.

4. Protein Binding Mechanism Probing

BD140 [for Albumin binding assay] is used in mechanistic studies aimed at understanding how albumin-binding ligands influence the fluorescence response of an albumin-associated reporter. In these experiments, investigators compare fluorescence behavior across structurally related ligands, concentration regimes, or assay conditions to infer binding-related trends and to contextualize how different chemotypes interact with albumin in vitro. The reagent's fluorescence-based readout provides a convenient platform for hypothesis-driven follow-up after initial screening results.